Pharmacology Pembrolizumab is A CTLA4 inhibitor B Monoclonal antibody against PDL1 receptor C Monoclonal antibody against PD1 ligand D Monochonal antibody against CDK416 💡 Explanation Pembrolizumab is ✓ Correct Answer: B. Monoclonal antibody against PDL1 receptor